Jump to content

Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Treatment of primary Sjogren syndrome: A systematic review

  • Please log in to reply
No replies to this topic

#1 CraigR


    Senior Silver Member

  • Members
  • PipPipPipPipPip
  • 438 posts
  • Location:Escondido (near San Diego), Ca

Posted 23 August 2010 - 06:21 AM

Treatment of primary Sjogren syndrome: A systematic review. In primary Sjögren syndrome, evidence from controlled trials suggests benefits for pilocarpine and cevimeline for sicca features and topical cyclosporine for moderate or severe dry eye. Anti–tumor necrosis factor agents have not shown clinical efficacy, and larger controlled trials are needed to establish the efficacy of rituximab. Manuel Ramos-Casals, MD, PhD. JAMA. 2010;304(4):452-460. (Also see: Treatments for Sjogren Syndrome)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Craig Roothoff
ISN Assistant News Guide
International Scleroderma Network(ISN)